SB345: Bill Text

SB345,14,7 450.035 (1t) A person engaged in the practice of pharmacy under s. 450.03 (1) (f) or (g) may not administer a prescribed drug product or device unless he or she has successfully completed a course of study and training in administration technique conducted by a course provider approved by the American Accreditation Council on Pharmaceutical Education or the board. A person engaged in the practice of pharmacy under s. 450.03 (1) (f) or (g) may administer a prescribed drug product or device under this subsection only under the direct supervision of a pharmacist who has successfully completed a course of study and training in administration technique conducted by a course provider approved by the American Accreditation Council on Pharmaceutical Education or the board, and only in the course of teaching self-administration techniques to a patient. A person engaged in the practice of pharmacy under s. 450.03 (1) (f) or (g) who administers a prescribed drug product or device under this subsection shall comply with the requirements and procedures established in rules promulgated by the board under s. 450.02 (2g) (b).

SB345,36 Section 36. 450.035 (2) of the statutes is amended to read:

SB345,14,15 450.035 (2) A pharmacist may not administer a vaccine unless he or she has successfully completed 12 hours in a course of study and training, approved by the American Accreditation Council on Pharmaceutical Education or the board, in vaccination storage, protocols, administration technique, emergency procedures, and record keeping and has satisfied the requirements specified in sub. (2t). A pharmacist may not administer a vaccine under this subsection to a person who is under the age of 6.

SB345,37 Section 37. 450.035 (2g) of the statutes is amended to read:

SB345,15,2 450.035 (2g) A person engaged in the practice of pharmacy under s. 450.03 (1) (f) or (g) may not administer a vaccine unless he or she acts under the direct supervision of a pharmacist and he or she and the supervising pharmacist have successfully completed 12 hours in a course of study and training, approved by the American Accreditation Council on Pharmaceutical Education or the board, in vaccination storage, protocols, administration technique, emergency procedures, and record keeping and the supervising pharmacist has satisfied the requirements specified in sub. (2t). A person engaged in the practice of pharmacy under s. 450.03 (1) (f) or (g) may not administer a vaccine under this subsection to a person who is under the age of 18.

SB345,38 Section 38. 450.05 of the statutes is amended to read:

SB345,15,15 450.05 Pharmacist licensed in other state; licensure. The board may, upon application and payment of the fee specified in s. 440.05 (2), license as a pharmacist any person who is licensed in another state if the person produces satisfactory evidence of having met requirements comparable to those that existed in this state at the time the person became licensed in the other state. The board shall not may deny a license as a pharmacist under this section to any person whose license to practice pharmacy in another state has been voluntarily surrendered, limited, suspended, or revoked. The board may require an applicant under this section to pass an equivalency examination administered by the board. If the board requires an equivalency examination, any person licensed as a pharmacist in another state who is engaged in the active practice of pharmacy may only be required to pass an examination on state and federal laws, rules, and regulations.

SB345,39 Section 39. 450.08 (1) of the statutes is amended to read:

SB345,15,19 450.08 (1) The renewal date for all licenses granted by the board is specified under s. 440.08 (2) (a). Only Except as provided under sub. (2) (a), only a holder of an unexpired license may engage in his or her licensed activity.

SB345,40 Section 40. 450.08 (2) (a) of the statutes is amended to read:

SB345,16,4 450.08 (2) (a) A pharmacist's license may be renewed by complying with continuing education requirements under s. 450.085 and paying the applicable fee determined by the department under s. 440.03 (9) (a) on or before the applicable renewal date specified under s. 440.08 (2) (a). Failure Notwithstanding s. 440.08 (3) (a), if a pharmacist fails to obtain renewal within the time period specified under this paragraph terminates the right of the person to be licensed as a pharmacist by that date, the board may suspend the pharmacist's license, and such right can only be acquired by passing the board may require the pharmacist to pass an examination to the satisfaction of the board to restore that license.

SB345,41 Section 41. 450.085 (1) of the statutes is amended to read:

SB345,16,14 450.085 (1) An applicant for renewal of a license under s. 450.08 (2) (a) shall submit proof that he or she has completed, within the 2-year period immediately preceding the date of his or her application, 30 hours of continuing education in courses conducted by a provider that is approved by the American Accreditation Council on Pharmaceutical Education or in courses approved by the board. Courses specified in s. 450.035 (1r) and (2) are courses in continuing education for purposes of this subsection. This subsection does not apply to an applicant for renewal of a license that expires on the first renewal date after the date on which the board initially granted the license.

SB345,42 Section 42. 450.19 (1) (a) of the statutes, as affected by 2013 Wisconsin Act 3, is renumbered 450.19 (1) (ar).

SB345,43 Section 43. 450.19 (1) (b) of the statutes, as affected by 2013 Wisconsin Act 3, is renumbered 450.19 (1) (ag) and amended to read:

SB345,16,21 450.19 (1) (ag) "Prescription Monitored prescription drug" means a substance identified in s. 961.16 or, 961.18, 961.20, or 961.22 or a drug identified by the board by rule as having a substantial potential for abuse.

SB345,44 Section 44. 450.19 (2) (intro.) of the statutes is amended to read:

SB345,16,25 450.19 (2) (intro.) The board shall establish by rule a program for monitoring the dispensing of monitored prescription drugs. The program shall do all of the following:

SB345,45 Section 45. 450.19 (2) (a) of the statutes is renumbered 450.19 (2) (a) (intro.) and amended to read:

SB345,17,8 450.19 (2) (a) (intro.) Require a pharmacist pharmacy or a practitioner to generate a record documenting each dispensing of a monitored prescription drug at the pharmacy or, if the monitored prescription drug is not dispensed at a pharmacy, by the practitioner and to deliver the record to the board, except that the program may not require the generation of a record when a in any of the following circumstances:

SB345,17,9 1. A monitored prescription drug is administered directly to a patient.

SB345,46 Section 46. 450.19 (2) (a) 2. of the statutes is created to read:

SB345,17,12 450.19 (2) (a) 2. A monitored prescription drug is compounded, packaged, or labeled in preparation for delivery but is not delivered.

SB345,47 Section 47. 450.19 (2) (a) 3. of the statutes is created to read:

SB345,17,17 450.19 (2) (a) 3. The prescription order is for a monitored prescription drug that is a substance listed in the schedule in s. 961.22 and is not a narcotic drug, as defined in s. 961.01 (15), and the prescription order is for a number of doses that is intended to last the patient 7 days or less.

SB345,48 Section 48. 450.19 (2) (b) of the statutes is amended to read:

SB345,17,23 450.19 (2) (b) Identify specific data elements to be contained in a record documenting the dispensing of a monitored prescription drug. In identifying specific data elements, the board shall consider data elements identified by similar programs in other states and shall ensure, to the extent possible, that records generated by the program are easily shared with other states.

SB345,49 Section 49. 450.19 (2) (d) of the statutes is amended to read:

SB345,18,3 450.19 (2) (d) Specify a secure electronic format for delivery of a record generated under the program and authorize the board to grant a pharmacist pharmacy or practitioner a waiver of the specified format.

SB345,50 Section 50. 450.19 (2) (f) of the statutes is amended to read:

SB345,18,6 450.19 (2) (f) Specify a penalty the discipline for failure to comply with rules promulgated under this subsection.

SB345,51 Section 51. 450.19 (3) (a) of the statutes is amended to read:

SB345,18,11 450.19 (3) (a) A pharmacy, pharmacist , or practitioner is immune from civil or criminal liability or professional discipline arising from the pharmacy's, pharmacist's, or practitioner's compliance in good faith with this section or with rules promulgated under this section.

SB345,52 Section 52. 450.19 (3) (b) of the statutes is amended to read:

SB345,18,16 450.19 (3) (b) Nothing in this section may be construed to require a pharmacy, pharmacist, or practitioner to obtain, before prescribing or dispensing a monitored prescription drug to a patient, information about the patient that has been collected pursuant to the program described established under sub. (2).

SB345,53 Section 53. 452.01 (4) of the statutes is amended to read:

SB345,18,22 452.01 (4) "Disciplinary proceeding" means a proceeding against one or more licensees or registrants in which the board may revoke, suspend, or limit a license or registration, reprimand a licensee or registrant, issue a private letter of warning to a licensee or registrant, or assess a forfeiture or require education or training under s. 452.14 (4m).

SB345,54 Section 54. 452.14 (4m) (intro.) of the statutes is amended to read:

SB345,19,3 452.14 (4m) (intro.) In addition to or in lieu of a reprimand, the issuance of a private letter of warning or a revocation, limitation, or suspension of a license or certificate of registration under sub. (3), the board may do any of the following:

SB345,55 Section 55. Initial applicability.

SB345,19,7 (1) The treatment of section 101.985 (5) (b) 1. and 2. b. of the statutes first applies to applications for renewals of licenses that are submitted to the department on the effective date of this subsection.

SB345,19,8 (End)